Rockefeller Capital Management L.P. Repligen Corp Transaction History

Rockefeller Capital Management L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$162.42 - $220.56 $162 - $220	-1 Reduced 0.12%	859 $145,000
Q3 2022 Nov 02, 2022	BUY	$160.42 - $256.21 $120,796 - $192,926	753 Added 703.74%	860 $160,000
Q2 2022 Aug 12, 2022	BUY	$140.68 - $188.02 $4,361 - $5,828	31 Added 40.79%	107 $17,000
Q1 2022 May 13, 2022	BUY	$161.19 - $257.96 $4,674 - $7,480	29 Added 61.7%	76 $14,000
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $16,588 - $20,399	-67 Reduced 58.77%	47 $12,000
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $2,142 - $3,566	11 Added 10.68%	114 $32,000
Q2 2021 Aug 10, 2021	SELL	$165.87 - $220.95 $7,961 - $10,605	-48 Reduced 31.79%	103 $20,000
Q1 2021 May 11, 2021	SELL	$180.37 - $226.26 $4,689 - $5,882	-26 Reduced 14.69%	151 $29,000
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $15,104 - $21,070	102 Added 136.0%	177 $33,000
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $9,188 - $11,870	75 New	75 $11,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.